Created by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the first SARS-CoV-2 vaccine to be registered anywhere in the world, with dozens of countries across Asia, Europe, Africa and Latin America expressing interest in obtaining it. Russia began a coroanvirus vaccination campaign using Sputnik V last month.
The New York Times has published a comprehensive article complete with colourful graphics detailing how Russia’s Gam-COVID-Vac, better known as Sputnik V, works.